(3Z)-Hex-3-en-1-yl cyclopropanecarboxylate
Common Name: |
(3Z)-Hex-3-en-1-yl cyclopropanecarboxylate |
IUPAC Name: |
[(Z)-hex-3-enyl] cyclopropanecarboxylate |
Molecular Formula: |
C14H20O2 |
SMILES: |
CCC=CCCOC(=O)C1CC1 |
Inchi: |
1S/C10H16O2/c1-2-3-4-5-8-12-10(11)9-6-7-9/h3-4,9H,2,5-8H2,1H3/b4-3- |
Inchi Key: |
AQALQDMWXUIMHX-ARJAWSKDSA-N |
Cas No: |
188570-78-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
220.31 |
Mass (g/mol) |
168.115 |
Molar Refractivity |
63.88 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
225.00 to 226.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.086 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.79 |
LogP |
2.296 |
iLOGP |
3.19 |
XLOGP3 |
3.41 |
WLOGP |
2.93 |
MLOGP |
3.19 |
ESOL Log S |
-3.09 |
ESOL Solubility (mg/ml) |
0.179 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.64 |
Ali Solubility (mg/ml) |
0.05 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.92 |
Silicos-IT Solubility (mg/ml) |
2.64 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.22 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.104 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.189 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |